New data at AAN reinforce clinical benefit of Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Basel, 26 April 2017 New data at AAN reinforce clinical benefit of Roche’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis OCREVUS rapidly suppressed signs of disease activity in relapsing MS (RMS) patients In patients with early RMS – recently diagnosed and without prior treatment – OCREVUS was superior to Rebif® (interferon beta-1a) in... Read more

Two Pore Guys Raises $24.5 Million in Series A Financing

Investment Led by Khosla Ventures with Eye on Developing an Industry for Diagnostics Based on the 2PG Platform April 25, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), today announced the close of a Series A venture financing round in the amount of $24.5 million, led by Khosla Ventures.... Read more

IONICON Presents the Revolutionary PTR-TOF 6000 X2 Trace Gas Analyzer

Next generation high-end PTR-TOFMS from the market leader for real-time VOC monitoring IONICON Analytik, the Austrian based leading manufacturer of real-time trace VOC analyzers introduces a new compact, ultra-sensitive and high-resolution PTR-TOF instrument. The PTR-TOF 6000 X2 is the first instrument in IONICON’s portfolio based on the new high-resolution release of the “ioniTOF” platform and our... Read more

MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

News Release April 25, 2017 Your Contact: Karen Tiano  +1 978 495 0093 Billerica, Massachusetts, April 25, 2017 — MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts. LabCentral is a private, non-profit organization that provides entrepreneurs and innovative life-sciences startups with lab space and... Read more